Topic

New York

A collection of 237 issues

Get Defitelio (Defibrotide) Covered by Aetna CVS Health in New York: Prior Authorization Guide & Appeals Process

Answer Box: Getting Defitelio Covered by Aetna CVS Health in New York Defitelio (defibrotide) requires prior authorization from Aetna CVS Health for hepatic veno-occlusive disease (VOD)/sinusoidal obstruction syndrome (SOS) with organ dysfunction post-transplant. Key requirements: documented VOD/SOS diagnosis using Baltimore or Cairo criteria, evidence of renal or pulmonary
7 min read

How to Get Mavenclad (Cladribine Tablets) Covered by Cigna in New York: A Complete Prior Authorization and Appeals Guide

Answer Box: Getting Mavenclad Covered by Cigna in New York Cigna requires prior authorization for Mavenclad (cladribine tablets) with strict step therapy requirements. You must document failure/intolerance of two other MS therapies OR one high-efficacy agent (Ocrevus, Tysabri, Kesimpta, Lemtrada, or Briumvi). Your neurologist submits the PA through Cigna&
5 min read

How Long Does It Take to Get Krystexxa (Pegloticase) Approved by Aetna (CVS Health) in New York? Timeline & Milestones

Answer Box: Getting Krystexxa Approved by Aetna in New York Standard timeline: 15-30 days for initial prior authorization; 72 hours for expedited appeals through New York DFS if urgent. Key requirements: G6PD deficiency screening (negative), failed conventional therapy documentation, rheumatologist prescription, and methotrexate co-therapy unless contraindicated. First step: Contact your
5 min read

How to Get Idelvion (Albutrepenonacog Alfa) Covered by UnitedHealthcare in New York: Prior Authorization, Appeals, and Coding Guide

Answer Box: Getting Idelvion Covered by UnitedHealthcare in New York Yes, UnitedHealthcare covers Idelvion (albutrepenonacog alfa) in New York, but requires prior authorization and often step therapy. The fastest path: Have your hematologist submit a PA request through the UnitedHealthcare Provider Portal using ICD-10 code D67 and HCPCS code J7202,
6 min read